Overview

SiNON Nano Sciences is a biotechnology company pioneering carbon-based nanotechnology for targeted drug delivery, with a primary focus on Central Nervous System (CNS) diseases. Our patented Carbon Nano Particle (CNP) platform is designed to efficiently cross the blood-brain barrier (BBB), enabling safer, more precise, and highly effective treatment delivery for neurological disorders, oncology, and other hard-to-treat conditions.

Operating at the intersection of nanomedicine, drug delivery, and precision therapeutics, SiNON is addressing critical challenges in the pharmaceutical industry by enhancing drug solubility, extending circulation time, and improving targeted release at disease sites. Our pH-tunable CNPs encapsulate a wide range of therapeutics, including biologics up to 500kD, while evading immune detection—offering a transformative approach to treating conditions with limited existing solutions.

SiNON Nano Sciences collaborates with pharmaceutical companies, research institutions, and investors to drive innovation in targeted therapeutics. Our mission is to redefine drug delivery, improve patient outcomes, and expand treatment access for neurological and systemic diseases worldwide.